PCA3 and PCA3-Based Nomograms Improve Diagnostic Accuracy in Patients Undergoing First Prostate Biopsy

PCA3 and PCA3-Based Nomograms Improve Diagnostic Accuracy in Patients Undergoing First Prostate Biopsy

While now recognized as an aid to predict repeat prostate biopsy outcome, the urinary PCA3 (prostate cancer gene 3) test has also been recently advocated to predict initial biopsy results. The objective is to evaluate the performance of the PCA3 test in predicting results of initial prostate biopsie...

Full description

Bibliographic Details
Main Authors: Virginie Vlaeminck-Guillem, Paul Perrin, Philippe Paparel, Claire Rodriguez-Lafrasse, Myriam Decaussin-Petrucci, Alain Ruffion, Denis Champetier, Marian Devonec
Format: Article
Language:English
Published: MDPI AG 2013-08-01
Series:International Journal of Molecular Sciences
Subjects:
urine biomarker
nomogram
initial prostate biopsy
prostate cancer
prostate cancer antigen 3
Online Access:http://www.mdpi.com/1422-0067/14/9/17767

Internet

http://www.mdpi.com/1422-0067/14/9/17767

Similar Items